​​​​
​​​​​​​​​​​​The Trusted Source for Preventive / Regenerative ​Medicine


​​​320 Santa Fe Drive, Suite 211

Encinitas, CA 92024

 760-635-1996

800-943-3331

​​​​​​​​​California HealthSpan Institute      

Batur P et al. Menopausal hormone therapy (HT) in patients with breast cancer. Maturitas. 2006 Jan 20;53(2):123-32


Blanchette S et al. Circulating progesterone and obesity in men. Horm Metab Res. 2006 May;38(5):330-5

Campagnoli C et al. Pregnancy progesterone and prgestins in relation to breast cancer risk. Journal of Steroid Biochemistry and Molecular Biology 97(2005,Dec)441-50

Fournier A et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005 Apr10;114(3):448-54

Fournier A et al. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Cancer Res treat. 2008 Jan;107(1):103-11

Grodstein F et al. The Role of Time since Menopause and Age at Hormone Initiation. Women’s Health J Hormone Therapy and Coronary Heart Disease: 2006 Jan/Feb;15

Klaiber EL et al. A critique of the Women’s Health Initiative hormone therapy study. Fertil Steril. 2005 Dec; 84(6):1589-601

Schmidt M et al. Inflammation and sex hormone metabolism. Ann N Y Acad Sci. 2006 Jun;1069:236-46

Schmidt JW et al. Hormone replacement therapy in menopausal women: Past problems and future possibilities. Gynecol Endocrinol. 2006 Oct;22(10):564-77

Progesterone